Bill > SB00554

This bill aims to amend existing state statutes to mandate that both individual and group health insurance policies cover biomarker testing. Biomarker testing is a medical diagnostic technique that involves measuring specific molecules (biomarkers) in the body that can indicate the presence of a disease, potential disease risk, or how a patient might respond to a particular treatment. By requiring insurance coverage for this type of testing, the bill seeks to make this potentially important diagnostic tool more accessible to patients by ensuring that health insurance plans will pay for biomarker tests, which can help in early disease detection, treatment planning, and personalized medical care. The bill does not provide extensive details about the specific types of biomarker tests that would be covered or any limitations on such coverage, but it represents a legislative effort to expand healthcare diagnostic options for individuals with health insurance in the state.

Business and Industry

https://www.cga.ct.gov/asp/cgabillstatus/cgabillstatus.asp?selBillType=Bill&bill_num=SB00554&which_year=2025